NX Development Corp | Finanzwire

Basculer en Français

10522	Companies
221921	Keywords
151096	Articles
117394	Press releases

Home
Companies
NX Development Corp

BRIEF

published on 06/21/2024 at 15:05, 1 year 11 months ago

NX Development Corp. Enrolls First Patient in OVA-302 Study After FDA Orphan Designation for Gleolan(R)

Gleolan NX Development Corp. OVA-302 Study FDA Orphan Designation
PRESS RELEASE

published on 06/21/2024 at 15:00, 1 year 11 months ago

NX Development Corp. Enrolls First Patient in OVA-302 Study After FDA Orphan Designation for Gleolan(R)
NX Development Corp. enrolls first patient in OVA-302 study for cancer management using Gleolan following FDA's Orphan Designation. CEO DeSena and Chairman Kosciessa express excitement for future programs

Gleolan NX Development Corp. OVA-302 Study Cancer Management Flourescence-guided Surgery
BRIEF

published on 03/05/2024 at 23:05, 2 years 2 months ago

NX Development Corp. Awarded Orphan-Drug Designation for Gleolan in Ovarian Cancer Treatment

FDA NX Development Corp Orphan-Drug Designation Gleolan Ovarian Cancer
PRESS RELEASE

published on 03/05/2024 at 23:00, 2 years 2 months ago

NX Development Corp. is Granted Orphan-Drug Designation Status by US FDA for Gleolan(R) in Ovarian and Related Cancers
NX Development Corp. has achieved orphan-drug status from the FDA for Gleolan, aiding in the visualization of ovarian tumors during surgery. The milestone highlights innovation in cancer care and surgery

FDA Cancer Care Gleolan NX Development Corp. Orphan-drug Status

Accesswire

Published on 06/05/2026 at 15:00, 1 hour 47 minutes ago

Norsemont Drills 20 Meters of 1.20 G/T Gold Equivalent at Bottom of Hole
Published on 06/05/2026 at 13:30, 3 hours 17 minutes ago

CANEX Announces Gold Basin Resources Shareholders Approve Merger Arrangement With CANEX With 75.82% Support
Published on 06/05/2026 at 13:00, 3 hours 47 minutes ago

Ur-Energy Reports Results of Annual General and Special Meeting of Shareholders
Published on 06/05/2026 at 08:00, 8 hours 47 minutes ago

Touchstone Exploration INC. Initial Results Of Fundraise
Published on 06/05/2026 at 04:00, 12 hours 47 minutes ago

Nano One Provides Summary of the Results from 2026 Annual General Meeting

View all ACCESSWIRE

EQS Group

Published on 06/05/2026 at 16:00, 47 minutes ago

Iute Announces Settlement and Listing of EUR 140 Million Tap of EUR 2025/2030 Bonds – Total Volume of Bonds Outstanding Reaches Benchmark Size of EUR 300 Million
Published on 06/05/2026 at 15:27, 1 hour 20 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Schroders plc
Published on 06/05/2026 at 15:26, 1 hour 21 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Intertek Group plc
Published on 06/05/2026 at 15:25, 1 hour 21 minutes ago

Form 8.3 - The Vanguard Group, Inc.: DCC plc
Published on 06/05/2026 at 15:24, 1 hour 22 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Beazley plc

Les Echos

Published on 06/05/2026 at 14:50, 1 hour 56 minutes ago

Guillemot Corporation | Information regarding the total number of voting rights and shares 31/05/2026
Published on 06/05/2026 at 13:56, 2 hours 51 minutes ago

Voting rights
Published on 06/04/2026 at 20:00, 20 hours 47 minutes ago

Schneider Electric announces the reference share price the initial conversion/exchange ratio of its €850 million new bonds convertible into new shares and/or exchangeable for existing shares (OCEANEs) due 2034 and the results of the repurchase of the OC
Published on 06/04/2026 at 18:23, 22 hours 24 minutes ago

Shareholders’ Meeting and board of directors’ meeting held on June 4, 2026
Published on 06/04/2026 at 18:00, 22 hours 47 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of May 29, 2026

View all LES ECHOS COMFI WIRE